Literature DB >> 30363705

New classification Rome IV functional dyspepsia and subtypes.

Seiji Futagami1, Hiroshi Yamawaki1, Shuhei Agawa1, Kazutoshi Higuchi1, Go Ikeda1, Hiroto Noda1, Kumiko Kirita1, Teppei Akimoto1, Mako Wakabayashi1, Noriko Sakasegawa1, Yasuhiro Kodaka1, Nobue Ueki1, Tetsuro Kawagoe1, Katsuhiko Iwakiri1.   

Abstract

Entities:  

Year:  2018        PMID： 30363705      PMCID： PMC6182037          DOI： 10.21037/tgh.2018.09.12

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


× No keyword cloud information.
  19 in total

Review 1.  The functional gastrointestinal disorders and the Rome III process.

Authors:  Douglas A Drossman
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

2.  Comparison of gastric emptying and plasma ghrelin levels in patients with functional dyspepsia and non-erosive reflux disease.

Authors:  Tomotaka Shindo; Seiji Futagami; Tetsuro Hiratsuka; Akane Horie; Tatsuhiko Hamamoto; Nobue Ueki; Masafumi Kusunoki; Kazumasa Miyake; Katya Gudis; Taku Tsukui; Katsuhiko Iwakiri; Choitsu Sakamoto
Journal:  Digestion       Date:  2009-02-27       Impact factor: 3.216

3.  Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia.

Authors:  J Tack; P Caenepeel; B Fischler; H Piessevaux; J Janssens
Journal:  Gastroenterology       Date:  2001-09       Impact factor: 22.682

Review 4.  Functional gastroduodenal disorders.

Authors:  Jan Tack; Nicholas J Talley; Michael Camilleri; Gerald Holtmann; Pinjin Hu; Juan-R Malagelada; Vincenzo Stanghellini
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

5.  Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study.

Authors:  Imran Aziz; Olafur S Palsson; Hans Törnblom; Ami D Sperber; William E Whitehead; Magnus Simrén
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-02-01

6.  Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.

Authors:  David A Peura; Thomas O G Kovacs; David C Metz; Nancy Siepman; Betsy L Pilmer; Nicholas J Talley
Journal:  Am J Med       Date:  2004-06-01       Impact factor: 4.965

7.  Role of impaired gastric accommodation to a meal in functional dyspepsia.

Authors:  J Tack; H Piessevaux; B Coulie; P Caenepeel; J Janssens
Journal:  Gastroenterology       Date:  1998-12       Impact factor: 22.682

8.  Impact of coexisting irritable bowel syndrome and non-erosive reflux disease on postprandial abdominal fullness and sleep disorders in functional dyspepsia.

Authors:  Seiji Futagami; Hiroshi Yamawaki; Mayumi Shimpuku; Nikki Izumi; Taiga Wakabayashi; Yasuhiro Kodaka; Hiroyuki Nagoya; Tomotaka Shindo; Tetsuro Kawagoe; Choitsu Sakamoto
Journal:  J Nippon Med Sch       Date:  2013       Impact factor: 0.920

9.  Epigastric pain syndrome accompanying pancreatic enzyme abnormalities was overlapped with early chronic pancreatitis using endosonography.

Authors:  Satomi Hashimoto; Seiji Futagami; Hiroshi Yamawaki; Keiko Kaneko; Yasuhiro Kodaka; Mako Wakabayashi; Noriko Sakasegawa; Shuhei Agawa; Kazutoshi Higuchi; Teppei Akimoto; Nobue Ueki; Tetsuro Kawagoe; Hitomi Sato; Katsuhisa Nakatsuka; Kaya Gudis; Chiaki Kawamoto; Takashi Akamizu; Choitsu Sakamoto; Katsuhiko Iwakiri
Journal:  J Clin Biochem Nutr       Date:  2017-08-18       Impact factor: 3.114

10.  Impact of sleep disorders, quality of life and gastric emptying in distinct subtypes of functional dyspepsia in Japan.

Authors:  Hiroshi Yamawaki; Seiji Futagami; Mayumi Shimpuku; Hitomi Sato; Taiga Wakabayashi; Yuuta Maruki; Yasuhiro Kodaka; Hiroyuki Nagoya; Tomotaka Shindo; Tetsuro Kawagoe; Choitsu Sakamoto
Journal:  J Neurogastroenterol Motil       Date:  2013-12-30       Impact factor: 4.924
View more
  8 in total

1.  Transcutaneous auricular vagal nerve stimulation improves functional dyspepsia by enhancing vagal efferent activity.

Authors:  Ying Zhu; Feng Xu; Dewen Lu; Peijing Rong; Jiafei Cheng; Miaomiao Li; Yaoyao Gong; Chao Sun; Wei Wei; Lin Lin; Jiande D Z Chen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-02-24       Impact factor: 4.052

Review 2.  Strategies to Refine Gastric Stimulation and Pacing Protocols: Experimental and Modeling Approaches.

Authors:  Leo K Cheng; Nipuni D Nagahawatte; Recep Avci; Peng Du; Zhongming Liu; Niranchan Paskaranandavadivel
Journal:  Front Neurosci       Date:  2021-04-22       Impact factor: 5.152

3.  Comparative efficacy and acceptability of psychotropic drugs for functional dyspepsia in adults: A systematic review and network meta-analysis.

Authors:  Wan Zhou; Xia Li; Yin Huang; Xiaoxiao Xu; Yan Liu; Jiayan Wang; Gang Nie; Dongdong Zhou
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

4.  Depression, anxiety and stress symptoms in patients presenting with dyspepsia at a regional hospital in KwaZulu-Natal province.

Authors:  Sijabulisiwe J Tshabalala; Andrew Tomita; Suvira Ramlall
Journal:  S Afr J Psychiatr       Date:  2019-10-21       Impact factor: 1.550

5.  Efficacy of modified Banxia Xiexin decoction in the management of Wei-Pi syndrome (postprandial distress syndrome): study protocol for a randomized, waitlist-controlled trial.

Authors:  Sai Ho Sin; Jing Wu; Yuchen Kang; Kar Hung Kevin Yip; Ngo Suet Kong; Hei Wan; Bacon Fung Leung Ng; Haiyong Chen
Journal:  Trials       Date:  2021-02-12       Impact factor: 2.279

6.  Efficacy evaluation of acupuncture combined with Liujunzi Decoction in the treatment of functional dyspepsia: A protocol of randomized controlled trial.

Authors:  Yulan Zhang; Lihong Bian; Huan Long; Weichen Zhang; Yuqiong Hu
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.817

Review 7.  Circadian Rhythms and Melatonin Metabolism in Patients With Disorders of Gut-Brain Interactions.

Authors:  Sophie Fowler; Emily C Hoedt; Nicholas J Talley; Simon Keely; Grace L Burns
Journal:  Front Neurosci       Date:  2022-03-09       Impact factor: 4.677

8.  Trimebutine Maleate Monotherapy for Functional Dyspepsia: A Multicenter, Randomized, Double-Blind Placebo Controlled Prospective Trial.

Authors:  Jannis Kountouras; Emmanuel Gavalas; Apostolis Papaefthymiou; Ioannis Tsechelidis; Stergios A Polyzos; Serhat Bor; Mircea Diculescu; Κhaled Jadallah; Mazurek Tadeusz; Tarkan Karakan; Αnna Bochenek; Jerzy Rozciecha; Piotr Dabrowski; Zeno Sparchez; Orhan Sezgin; Macit Gülten; Niazy Abu Farsakh; Michael Doulberis
Journal:  Medicina (Kaunas)       Date:  2020-07-08       Impact factor: 2.430
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.